3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lymphoma
5
Lung Neoplasms
5
Multiple Myeloma
4
Lymphoma, Large-Cell, Anaplastic
4
Neuroblastoma
3
Neoplasms
2
Hematologic Neoplasms
2
Carcinoma
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Neurofibromatosis 2
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Lobular
1
Carcinoma, Large Cell
1
Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
1
Advanced Cancer
1
Adenocarcinoma of Lung
1
Adenocarcinoma
1
ALK-positive NSCLC
1
ALK or ROS1-positive NSCLC
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
Crizotinib
×
Clear all
No trials found.